Clinical Trial Update: Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 comparative trial evaluating BAY86-5300 for dysmenorrhea. The study compared BAY86-5300 with a flexible extend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• BAY86-5300

Snippet

Sponsor: Bayer | Conditions: Dysmenorrhea | Phase 3 | Status: COMPLETED